Payment & Shipping Terms:
|Products Name:||Dutasteride||Drug Class:||Anabolic Androgenic Steroids|
|Alias:||Avodart ; Duagen||Email:||Richard@diamondrawsteroid.com|
Alias: Avodart ; Duagen
CAS NO: 164656-23-9
|Product name||Dutasteride Factory Supplying|
|Other name||DUTASTERIDE; Duagen; Avodart|
|CAS register number||164656-23-9|
Dutasteride (trademark name Avodart) is a dual 5-α reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT). Used for benign prostatic hyperplasia; however, it increases the risk of erectile dysfunction and decreased sexual desire.
Dutasteride useful for the symptoms of benign prostatic hyperplasia (BPH); colloquially known as an "enlarged prostate".
In those who are being regularly screened 5-alpha-reductase inhibitor (finasteride and dutasteride) reduce the overall risk of being diagnosed with prostate cancer however there is insufficient data to determine if they have an effect on the risk of death and may increase the chance of more serious cases.
This class of medications increases rates of erectile dysfunction (with between 5% and 9% developing problems after starting their use). This is linked to lower quality of life and can cause stress in relationships. There is also an association with lowered sexual desire. It has been reported that these adverse sexual side effects may persist even after discontinuation of the drug.
The FDA has added a warning to dutasteride about an increased risk of high-grade prostate cancer. While the potential for positive, negative or neutral changes to the potential risk of developing prostate cancer with dutasteride has not been established, evidence has suggested it may temporarily reduce the growth and prevalence of benign prostate tumors, but could also mask the early detection of prostate cancer. The primary area for concern is for patients who may develop prostate cancer whilst taking dutasteride for benign prostatic hyperplasia, which in turn could delay diagnosis and early treatment of the prostate cancer, thereby potentially increasing the risk of these patients developing high-grade prostate cancer.
COA and HPLC:
|Appearance||White crystalline powder|
|Identification||By UV, To match with working standard||Complies|
|Related Substances||Not more than the reference solution (0.05%)||Complies|
|Loss on drying||＜0.5%||0.2%|
|Resiue on ignition||≤0.1%||0.05%|
Packaging & Delivery:
We have professional team for package and shipment. Special way to ship 100 grams to 100kg powders at one time to your country. Fast and discreet shipment could be arranged for customs pass Guaranteed.
1. Shenzhen Diamond Pharmaceutical Technology Co., ltd is a professional standard GMP raw powder manufacture that approved by the government in China for over 10 years, and all powders are factory directly-selling,and is top quality
2.Our products have exported to USA, Australia, Germany, Norway, Poland, Finland, Spain, UK, France, Russia,and many other countries, over 3000t/month.
3. Professional team special for package and shipment and pay close attention to the delivery dynamic 24hours for customs. And 100% pass to UK, Norway, Poland, Spain, USA, Canada, Brazil; 98% pass to Germany, Russia, Australia, New Zealand.
4. Most of the powders are in stock, Chargeable samples are available, and could be
shipped out within 24hours.
5. High quality,good price, fast and safety delivery Shipment by DHL,TNT,FEDEX,
Contact Person: sales